Literature DB >> 22556171

Association between TaqIB polymorphism of cholesteryl ester transfer protein and coronary artery disease in the Chinese population.

Qi Yu1, En-qi Liu, Si-hai Zhao, Ya-feng Li, Yan-li Wang, Yu-long Chen, Ke-na Wei, Bing-qiao Huang, Jian-lin Fan, Peng-hui Yang.   

Abstract

OBJECTIVE: To assess whether the TaqIB polymorphism of cholesteryl ester transfer protein (CETP) is associated with coronary artery disease (CAD) in Chinese population, we performed a meta-analysis in this paper.
METHODS: We searched PubMed, Embase, the Science Citation Index (SCI), the China Biological Medicine database (CBM), the China National Knowledge Infrastructure (CNKI), and the Wanfang database for relevant articles. Data were extracted, and pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated.
RESULTS: The literature search yielded 448 studies, in which 10 case-control studies including 1694 cases and 1456 controls matched the selection criteria. The combined B1 and B2 allele frequencies were 0.587 and 0.413, respectively. The pooled OR was 1.10 (95% CI, 0.89-1.34) for comparing the B1B1 or B1B2 carriers with B2B2 carriers, and was 1.27 (95% CI, 1.09-1.49) in the B1B1 carriers versus B2B2 or B1B2 carriers.
CONCLUSIONS: In the present study, the TaqIB polymorphism of CETP was found to be associated with CAD in the Chinese population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22556171      PMCID: PMC3348224          DOI: 10.1631/jzus.B1100264

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  22 in total

1.  A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men.

Authors:  Simin Liu; Christian Schmitz; Meir J Stampfer; Frank Sacks; Charles H Hennekens; Klaus Lindpaintner; Paul M Ridker; Simm Liu
Journal:  Atherosclerosis       Date:  2002-04       Impact factor: 5.162

2.  Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: a study based on coronary angiography.

Authors:  A Goto; K Sasai; S Suzuki; T Fukutomi; S Ito; T Matsushita; M Okamoto; T Suzuki; M Itoh; K Okumura-Noji; S Yokoyama
Journal:  Atherosclerosis       Date:  2001-11       Impact factor: 5.162

3.  Influence of CETP gene variation on plasma lipid levels and coronary heart disease: a survey in Taiwan.

Authors:  J H Wu; Y T Lee; H C Hsu; L L Hsieh
Journal:  Atherosclerosis       Date:  2001-12       Impact factor: 5.162

Review 4.  Cholesteryl ester transfer protein, high density lipoprotein and arterial disease.

Authors:  P J Barter; K A Rye
Journal:  Curr Opin Lipidol       Date:  2001-08       Impact factor: 4.776

Review 5.  Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis.

Authors:  Philip J Barter; H Bryan Brewer; M John Chapman; Charles H Hennekens; Daniel J Rader; Alan R Tall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-01       Impact factor: 8.311

6.  The frequency of the cholesteryl ester transfer protein-TaqI B2 allele is lower in African Americans than in Caucasians.

Authors:  Marina Cuchel; Megan L Wolfe; Andrew S deLemos; Daniel J Rader
Journal:  Atherosclerosis       Date:  2002-07       Impact factor: 5.162

7.  Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction.

Authors:  M Corbex; O Poirier; F Fumeron; D Betoulle; A Evans; J B Ruidavets; D Arveiler; G Luc; L Tiret; F Cambien
Journal:  Genet Epidemiol       Date:  2000-07       Impact factor: 2.135

8.  The association of cholesteryl ester transfer protein polymorphism with high-density lipoprotein cholesterol and coronary artery disease in Koreans.

Authors:  K-W Park; J-H Choi; H-K Kim; S Oh; I-H Chae; H-S Kim; B-H Oh; M-M Lee; Y-B Park; Y-S Choi
Journal:  Clin Genet       Date:  2003-01       Impact factor: 4.438

9.  Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.

Authors:  Margaret E Brousseau; John J O'Connor; Jose M Ordovas; Dorothea Collins; James D Otvos; Tatyana Massov; Judith R McNamara; Hanna B Rubins; Sander J Robins; Ernst J Schaefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-07-01       Impact factor: 8.311

10.  Cholesteryl ester transfer protein genetic polymorphisms, HDL cholesterol, and subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Michael Y Tsai; Craig Johnson; W H Linda Kao; A Richey Sharrett; Valerie L Arends; Richard Kronmal; Nancy Swords Jenny; David R Jacobs; Donna Arnett; Daniel O'Leary; Wendy Post
Journal:  Atherosclerosis       Date:  2008-02-20       Impact factor: 5.162

View more
  3 in total

Review 1.  Estrogen receptor α gene PvuII polymorphism and coronary artery disease: a meta-analysis of 21 studies.

Authors:  Jie Ding; Hui Xu; Xiang Yin; Fu-rong Zhang; Xiao-ping Pan; Yi-an Gu; Jun-zhu Chen; Xiao-gang Guo
Journal:  J Zhejiang Univ Sci B       Date:  2014-03       Impact factor: 3.066

2.  Estrogen receptor alpha polymorphisms, estradiol level, and occurrence of atherosclerosis risk factors in healthy postmenopausal women.

Authors:  Iwona Bojar; Mariusz Gujski; Dorota Raczkiewicz; Robert Łyszcz; Jakub Owoc; Irena Walecka
Journal:  Med Sci Monit       Date:  2015-04-03

3.  Relationship between CETP gene polymorphisms with coronary artery disease in Polish population.

Authors:  Joanna Iwanicka; Tomasz Iwanicki; Paweł Niemiec; Anna Balcerzyk; Jolanta Krauze; Sylwia Górczyńska-Kosiorz; Anna Ochalska-Tyka; Władysław Grzeszczak; Iwona Żak
Journal:  Mol Biol Rep       Date:  2018-09-03       Impact factor: 2.316

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.